A Peptoid “Antibody Surrogate” That Antagonizes VEGF Receptor 2 Activity-Reference-Cited by-同舟云学术

A Peptoid “Antibody Surrogate” That Antagonizes VEGF Receptor 2 Activity

Published:2008-04-01 Issue:17 Volume:130 Page:5744-5752
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Udugamasooriya D. Gomika¹,Dineen Sean P.¹,Brekken Rolf A.¹,Kodadek Thomas¹

Affiliation:

1. Division of Translational Research, Departments of Internal Medicine, Surgery, and Pharmacology, and Hamon Center for Therapeutic Oncology Research and Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9185

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja711193x

Reference50 articles.

1. Anti-TNF.ALPHA. Therapy for Rheumatoid Arthritis: An Update.

2. The promise of targeted therapy: cancer drugs become more specific.

3. Therapeutic cancer targeting peptides

4. Is antibody therapy of tumor compromised by infusion-related reactions?

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinatorial Libraries of Bipodal Binders of the Insulin Receptor;ChemMedChem;2024-04-11

2. Catalytic Protein Inhibitors;Angewandte Chemie International Edition;2024-01-12

3. Catalytic Protein Inhibitors;Angewandte Chemie;2024-01-12

4. Linker optimization and activity validation of a cell surface vimentin targeted homo-dimeric peptoid antagonist for lung cancer stem cells;Bioorganic & Medicinal Chemistry;2024-01

5. Conformational Studies of β‐Azapeptoid Foldamers: A New Class of Peptidomimetics with Confined Dihedrals;Chemistry – A European Journal;2023-12-07